Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials

OBJECTIVE: INGR1D (INvestigating Genetic Risk for type 1 Diabetes) was a type 1 diabetes (T1D) genetic screening study established to identify participants for a primary prevention trial (POInT, Primary Oral Insulin Trial). METHODS: The majority of participants were recruited by research midwives in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bendor-Samuel, Owen Martyn, Wishlade, Tabitha, Willis, Louise, Aley, Parvinder, Choi, Edward, Craik, Rachel, Mujadidi, Yama, Mounce, Ginny, Roseman, Fenella, De La Horra Gozalo, Arancha, Bland, James, Taj, Nazia, Smith, Ian, Ziegler, Anette-Gabriele, Bonifacio, Ezio, Winkler, Christiane, Haupt, Florian, Todd, John A, Servais, Laurent, Snape, Matthew D, Vatish, Manu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763160/
https://www.ncbi.nlm.nih.gov/pubmed/36171064
http://dx.doi.org/10.1136/archdischild-2022-324270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763160/
https://www.ncbi.nlm.nih.gov/pubmed/36171064
http://dx.doi.org/10.1136/archdischild-2022-324270

Ejemplares similares